Azacitidine in outpatient treatment – single center experience

AIM OF THE STUDY: Azacitidine is a hypomethylating agent which is used in the treatment of myelodysplastic syndromes, acute myeloid leukemia and chronic myelomonocytic leukemia. Because of good tolerance to the drug, azacitidine can be administered both during hospitalization and in an outpatient se...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Contemp Oncol (Pozn)
Autori principali: Rybka, Justyna, Stefanko, Ewa, Bogucka-Fedorczuk, Aleksandra, Butrym, Aleksandra, Poręba, Rafał, Kuliczkowski, Kazimierz, Wróbel, Tomasz
Natura: Artigo
Lingua:Inglês
Pubblicazione: Termedia Publishing House 2016
Soggetti:
Original Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4731453/
https://ncbi.nlm.nih.gov/pubmed/26843844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2015.56653
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi